Does Caplacizumab for the management of thrombotic thrombocytopenic purpura increase the risk of relapse, exacerbation, and bleeding? An updated systematic review and meta‐analysis... by Niraj Neupane, Sangharsha Thapa, Amir Mahmoud, Abhinav Bhattarai, Anil KC, Shreeja Shikhrakar, Sayuri Gurusinghe, Peter Kuiodes

Get full text